인쇄하기
취소

VM202 selected as Biostar research project

Published: 2008-10-31 06:52:00
Updated: 2008-10-31 06:52:00
The ministry of Knowledge Economy has announced that ViroMed Co.’s VM202 (DNA-based medicine for ischemic disease including peripheral and coronary artery disease) has been designated as one of the nation’s Biostar research projects in 2008.

The government plans to spend a 50-billion research fund to ViroMed for the next five years as part of efforts to boost the company’s research and devel...

Fees

- Email service daily and homepage access.
  1. $300 per month.
  2. 5 Email holders per each company.
  3. Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.